• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS PROGRIP; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION SAS PROGRIP; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number UNKNOWN PROGRIP
Device Problems Migration or Expulsion of Device (1395); Material Deformation (2976); Mechanics Altered (2984); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Adhesion(s) (1695); Emotional Changes (1831); Hemorrhage/Bleeding (1888); Inflammation (1932); Nerve Damage (1979); Neuropathy (1983); Pain (1994); Scar Tissue (2060); Seroma (2069); Hernia (2240); Distress (2329); Discomfort (2330); Fluid Discharge (2686); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an inguinal hernia.It was reported that after the implant, the patient experienced pain, suffering, emotional distress, diminished quality of life, recurrence, meshoma, mesh entrapment of the cord structure, neuropathic inguinodynia, adhesions, extruded mesh, mesh folded, scar, bleeding, wrapped mesh, inguinal pain, inflammatory responses, discomfort, mental anguish, impairment of daily living, device defective, mental pain, disability, permanent impairment loss of enjoyment of life.Post-operative patient treatment included revision surgery, neurectomy of the ilioinguinal and iliohypogastrict nerves, adhesions extruded, medication, nerve blocks.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an inguinal hernia.It was reported that after the implant, the patient experienced nerve damage, inguinal nerve and spermatic chord injuries, seroma, drainage, pain, suffering, emotional distress, diminished quality of life, recurrence, meshoma, mesh entrapment of the cord structure, neuropathic inguinodynia, adhesions, extruded mesh, mesh folded, mesh migration, scar, bleeding, wrapped mesh, inguinal pain, inflammatory responses, discomfort, mental anguish, impairment of daily living, device defective, mental pain, disability, permanent impairment loss of enjoyment of life.Post-operative patient treatment included revision surgery, hernia repair with new mesh, mesh removal, neurectomy of the ilioinguinal and iliohypogastrict nerves, adhesions extruded, medication, loss of testicles, nerve blocks.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an inguinal hernia.It was reported that after the implant, the patient experienced nerve damage, inguinal nerve and spermatic chord injuries, seroma, drainage, pain, suffering, emotional distress, diminished quality of life, recurrence, meshoma, mesh entrapment of the cord structure, neuropathic inguinodynia, adhesions, extruded mesh, mesh folded, mesh migration, scar, bleeding, wrapped mesh, inguinal pain, inflammatory responses, discomfort, mental anguish, impairment of daily living, device defective, mental pain, disability, permanent impairment, loss of enjoyment of life, & hydrocele.Post-operative patient treatment included revision surgery, hernia repair with new mesh, mesh removal, neurectomy of the ilioinguinal and iliohypogastric nerves, adhesions extruded, medication, loss of testicles, nerve blocks, exploratory surgery of right groin, removal of testicular cord, hospitalization, pain injections, multiple drainages of seroma, nerve block, ct/mri scan, & right orchiectomy.
 
Manufacturer Narrative
Ime e2402: hydrocele.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGRIP
Type of Device
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR  01600
Manufacturer (Section G)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR   01600
Manufacturer Contact
justin ellis
8200 coral sea st ne
mounds view, MN 55112
7635265677
MDR Report Key15755054
MDR Text Key303277171
Report Number9615742-2022-01057
Device Sequence Number1
Product Code FTL
UDI-Device Identifier10884521177697
UDI-Public10884521177697
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K081050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 03/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/08/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2018
Device Model NumberUNKNOWN PROGRIP
Device Catalogue NumberUNKNOWN PROGRIP
Device Lot NumberSBO0807X
Was Device Available for Evaluation? No
Date Manufacturer Received03/15/2023
Date Device Manufactured11/27/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Disability; Required Intervention;
Patient SexMale
Patient Weight82 KG
-
-